Джон Макдугалл - Энергия крахмала
50. Lund V, Mejdell CM, Rocklinsberg H, et al. Expanding the moral circle: farmed fish as objects of moral concern. Dis Aquat Organ. 2007 May 4; 75 (2): 109–18.
Глава 10. Толстый веган
1. Spence LA, Lipscomb ER, Cadogan J, et al. The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study. Am J Clin Nutr. 2005 Apr; 81 (4): 916–22.
2. Roughead ZK, Hunt JR, Johnson LK, et al. Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab. 2005 Jan; 90 (1): 181–89.
3. Kerstetter JE, Wall DE, O’Brien KO, et al. Meat and soy protein affect calcium homeostasis in healthy women. J Nutr. 2006 Jul; 136 (7): 1890–95.
4. Arjmandi BH, Khalil DA, Smith BJ, et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88 (3): 1048–54.
5. Khalil DA, Lucas EA, Juma S, et al. Soy protein supplementation increases serum insulinlike growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr. 2002 Sep; 132 (9): 2605–8.
6. Sauer LA, Blask DE, Dauchy RT. Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem. 2007 Oct; 18 (10): 637–49.
7. Griffini P. Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res. 1998 Aug 1; 58 (15): 3312–19.
8. Coulombe J, Pelletier G, Tremblay P, et al. Influence of lipid diets on the number of metastases and ganglioside content of H59 variant tumors. Clin Exp Metastasis. 1997 Jul; 15 (4): 410–17.
9. Klieveri L. Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation. Clin Exp Metastasis. 2000; 18 (5): 371–77.
10. Thiäbaut AC, Kipnis V, Chang SC, et al. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst. 2007 Mar 21; 99 (6): 451–62.
11. Ferrari R, Rapezzi C. The Mediterranean diet: a cultural journey. Lancet. 2011 May 1; 377 (9779): 1730–31.
12. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 1995 Jun; 61 (6 Suppl): 1321S–23S.
13. Brown JM, Shelness GS, Rudel LL. Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep. 2007 Dec; 9 (6): 494–500.
14. Blankenhorn DH, Johnson RL, Mack WJ, et al. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA. 1990 Mar 23–30; 263 (12): 1646–52.
15. Felton CV, Crook D, Davies MJ, Oliver MF. Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet. 1994 Oct 29; 344 (8931): 1195–96.
16. Sanders TA, de Grassi T, Miller GJ, Humphries SE. Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism. Am J Clin Nutr. 1999; 69: 220–25.
17. Larsen LF, Bladbjerg EM, Jespersen J, Marckmann P. Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler Thromb Vasc Biol. 1997 Nov; 17 (11): 2904–9.
18. Friedman M, Rosenman RH, Byers SO. Serum lipids and conjunctival circulation after fat ingestion in men exhibiting type-A behavior patterns. Circulation. 1964 Jun; 29: 874–86.
19. Friedman M, Byers SO, Rosenman RH. Effect of unsaturated fats upon lipemia and conjunctival circulation. A study of coronary-prone (pattern A) men. JAMA. 1965 Sep 13; 193: 882–86.
20. Kuo P, Whereat AF, Horwitz O. The effect of lipemia upon coronary and peripheral arterial circulation in patients with essential hyperlipemia. Am J Med. 1959 Jan; 26 (1): 68–75.
21. Natoli S, McCoy P. A review of the evidence: nuts and body weight. Asia Pac J Clin Nutr. 2007; 16 (4): 588–97.
22. Sacks FM, Lichtenstein A, Van Horn L, et al; American Heart Association Nutrition Committee. Soy protein, isof lavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006 Feb 21; 113 (7): 1034–44.
23. Cassileth BR, Vickers AJ. Soy: an anticancer agent in wide use despite some troubling data. Cancer Invest. 2003; 21 (5): 817–18.
24. Lu L. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996 Jan; 5 (1): 63–70.
25. Divi R. Anti-thyroid isof lavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997 Nov 15; 54 (10): 1087–96.
26. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002 Jun; 110 Suppl 3: 349–53.
27. Yellayi S. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA. 2002 May 28; 99 (11): 7616–21.
28. Zoppi G. Immunocompetence and dietary protein intake in early infancy. J Pediatr Gastroenterol Nutr. 1982; 1 (2): 175–82.
29. Zoppi G. Gammaglobulin level and soy-protein intake in early infancy. Eur J Pediatr. 1979 Apr 25; 131 (1): 61–9.
30. Zoppi G. Diet and antibody response to vaccinations in healthy infants. Lancet. 1983 Jul 2; 2 (8340): 11–14.
31. Fort P. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J Am Coll Nutr. 1990 Apr; 9 (2): 164–67.
32. Alexandersen P. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA. 2001 Mar 21; 285 (11): 1482–88.
33. White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr. 2000 Apr; 19 (2): 242–55.
34. Reddy ST. Effect of low-carbohydrate high-protein diets on acid-base balance, stoneforming propensity, and calcium metabolism. Am J Kidney Dis. 2002 Aug; 40 (2): 265–74.
35. Jenkins DJ, Kendall CW, Vidgen E, et al. Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women. Eur J Clin Nutr. 2003 Feb; 57 (2): 376–82.
36. Yu H. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000 Sep 20; 92 (18): 1472–89.
37. Bartke A, Chandrashekar V, Dominici F, et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontolog y. 2003; 4 (1): 1–8.
38. Miller RA. Genetic approaches to the study of aging. J Am Geriatr Soc. 2005 Sep; 53 (9 Suppl): S284–86.
39. Holzenberger M. The GH/IGF-I axis and longevity. Eur J Endocrinol. 2004 Aug; 151 Suppl 1: S23–7.
40. Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science. 2007 Apr 6; 316 (5821): 112–15.
41. Samaras TT, Elrick H, Storms LH. Is height related to longevity? Life Sci. 2003 Mar 7; 72 (16): 1781–1802.
42. Siegel-Itzkovich J. Health committee warns of potential dangers of soya. BMJ. 2005 Jul 30; 331 (7511): 254.
43. Turck D. Soy protein for infant feeding: what do we know? Curr Opin Clin Nutr Metab Care. 2007 May; 10 (3): 360–65.
44. www.wholesoystory.com/newsletters/FrenchWARNING.pdf.
45. www.babycareadvice.com/babycare/general_help/article.php?id=43.
Глава 11. Хотите быть в безопасности — не принимайте БАДы!
1. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008 Apr 16; (2): CD007176.
2. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008 Jul 16; (3): CD004183.
3. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981 Mar 19; 290 (5803): 201–8.
4. Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer. 1975 Apr 15; 15 (4): 561–65.
5. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994 Apr 14; 330 (15): 1029–35.
6. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996 May 2; 334 (18): 1150–55.
7. Pietrzik K. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med. 1996 Oct 3; 335 (14): 1065–66.
8. Bjelakovic G, Gluud C. Vitamin and mineral supplement use in relation to all-cause mortality in the Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1633–34.
9. Redberg RF. Vitamin supplements: more cost than value: comment on “dietary supplements and mortality rate in older women.” Arch Intern Med. 2011 Oct 10; 171 (18): 1634–35.
10. Lee JE, Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterolog y. 2011 Jul; 141 (1): 16–20.
11. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39–51.
12. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306 (14): 1549–56.
13. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6; 360 (9326): 23–33.
14. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and betacarotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997 Jun 14; 349 (9067): 1715–20.
15. Mursu J, Robien K, Harnack LJ, et al. Dietary Supplements and Mortality Rate in Older Women: The Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1625–33.
16. Lonn E, Bosch J, Yusuf S, et al; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 Mar 16; 293 (11): 1338–47.
17. Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004 Jun 24; 350 (26): 2673–81.
18. Bønaa KH, Njølstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13; 354 (15): 1578–88.
19. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008 May 7; 299 (17): 2027–36.
20. Durga J, Bots ML, Schouten EG, et al. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr. 2011 May; 93 (5): 941–49.
21. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010 Jun 23; 303 (24): 2486–94.
22. House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010 Apr 28; 303 (16): 1603–9.
23. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral Vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010 May 12; 303 (18): 1815–22.
24. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002 Aug 14; 288 (6): 715–21.
Витамин D
25. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010 Mar 2; 152 (5): 307–14.
26. Grey A, Bolland MJ, Reid IR. Vitamin D supplementation. Arch Intern Med. 2010 Mar 22; 170 (6): 572–73.
27. Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Internal Med. 2000; 247: 260–68.
28. Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003; 88: 296–307.
29. Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol. 2006 Sep; 92 (1): 9–16.
30. Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population. Horm Metab Res. 2009 May; 41 (5): 402–7.
31. Salamone LM, Dallal GE, Zantos D, et al. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am J Clin Nutr. 1994 Jan; 59 (1): 80–86.
32. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69: 84256.
33. Holick MF. Sunlight Dilemma: risk of skin cancer or bone disease and muscle weakness. Lancet. 2001; 357: 46.
34. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006 Feb; 54 (2): 301–17.
